Quest Diagnostics Incorporated
Stock Forecast, Prediction & Price Target

Quest Diagnostics Incorporated (DGX) stock Price Target by analysts

Last Year
Average Price Target

$173.83

Potential downside: -4.92%

Based on 6 analysts

Quest Diagnostics Incorporated price prediction

Strike.market

What is Quest Diagnostics Incorporated stock analysts` prediction?

Quest Diagnostics Incorporated stock forecast: Based on 6 Wall Street analysts` predicted price targets for Quest Diagnostics Incorporated in the last 3 months, the avarage price target is $173.83, with a high forecast of $NaN. The average price target represents a -4.92% change from the last price of $182.83.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

Quest Diagnostics Incorporated stock Price Target by analysts

Full breakdown of analysts given Quest Diagnostics Incorporated price targets

Analyst name & company
Analyst win rate
Publish date
Price target
Price when posted
Source Historical targets
Patrick Donnelly
Citigroup
0%
0/1
11 months ago $185 1.18% upside $157.47 TheFly
Previous targets (0)
Michael Cherny
Leerink Partners
0%
0/1
11 months ago $165 -9.75% downside $157.47 StreetInsider
Previous targets (0)
Eric Coldwell
Robert W. Baird
0%
0/2
11 months ago $182 -0.45% downside $157.47 StreetInsider
Previous targets (1)
Stephanie Davis
Barclays
0%
0/2
11 months ago $168 -8.11% downside $157.47 TheFly
Previous targets (1)
Paige Meyer
CFRA
0%
0/1
11 months ago $178 -2.64% downside $157.46 StreetInsider
Previous targets (0)
David MacDonald
Truist Financial
0%
0/2
11 months ago $165 -9.75% downside $150.79 TheFly
Previous targets (1)
Ann Hynes
Mizuho Securities
0%
0/1
about 1 year ago $160 -12.48% downside $143.21 StreetInsider
Previous targets (0)
Eric Coldwell
Robert W. Baird
0%
0/2
about 1 year ago $154 -15.76% downside $140.96 TheFly
Previous targets (1)
David MacDonald
Truist Financial
0%
0/2
about 1 year ago $158 -13.58% downside $144.11 TheFly
Previous targets (1)
Stephanie Davis
Barclays
0%
0/2
over 1 year ago $144 -21.23% downside $137.55 TheFly
Previous targets (1)
Brian Tanquilut
Jefferies
0%
0/1
over 1 year ago $155 -15.22% downside $127.42 StreetInsider
Previous targets (0)
Unknown
Wells Fargo
N/A
over 2 years ago $140 -23.42% downside $143.29 Benzinga
N/A
Unknown
Morgan Stanley
N/A
over 2 years ago $158 -13.58% downside $155.5 Benzinga
N/A
Unknown
Citigroup
N/A
almost 3 years ago $125 -31.63% downside $149.27 Benzinga
N/A
Unknown
Morgan Stanley
N/A
over 3 years ago $142 -22.33% downside $136.13 Benzinga
N/A
Unknown
Wells Fargo
N/A
over 3 years ago $150 -17.95% downside $133.75 Benzinga
N/A
Ralph Giacobbe
Citigroup
0%
0/1
over 3 years ago $175 -4.28% downside $140 Pulse 2.0
Previous targets (0)
Pito Chickering
Deutsche Bank
0%
0/1
over 3 years ago $190 3.92% upside $142.3 Pulse 2.0
Previous targets (0)
Donald Hooker
KeyBanc
100%
1/1
over 3 years ago $170 -7.01% downside $161.75 Investing
Previous targets (0)
A.J. Rice
Credit Suisse
100%
1/1
almost 4 years ago $150 -17.95% downside $155.22 TheFly
Previous targets (0)

Quest Diagnostics Incorporated Financial Estimates

Quest Diagnostics Incorporated Revenue Estimates

Quest Diagnostics Incorporated EBITDA Estimates

Quest Diagnostics Incorporated Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$10.78B
 
N/A
$9.88B
 
-8.38%
$9.25B
 
-6.38%
Avg: $9.76B
Low: $9.71B
High: $9.90B
avg. 5.53%
Avg: $10.10B
Low: $10.01B
High: $10.18B
avg. 3.45%
Avg: $10.62B
Low: $10.52B
High: $10.71B
avg. 5.15%
Avg: $10.87B
Low: $10.77B
High: $10.96B
avg. 2.35%
Net Income
 
% change YoY
$1.99B
 
N/A
$946M
 
-52.58%
$854M
 
-9.72%
Avg: $970.18M
Low: $924.34M
High: $1.07B
avg. 13.60%
Avg: $1.06B
Low: $1.01B
High: $1.20B
avg. 9.95%
Avg: $1.25B
Low: $1.23B
High: $1.26B
avg. 17.51%
Avg: $1.34B
Low: $1.32B
High: $1.35B
avg. 7.00%
EBITDA
 
% change YoY
$3.15B
 
N/A
$1.81B
 
-42.68%
$1.73B
 
-4.30%
Avg: $2.20B
Low: $2.19B
High: $2.23B
avg. 27.29%
Avg: $2.28B
Low: $2.26B
High: $2.30B
avg. 3.45%
Avg: $2.39B
Low: $2.37B
High: $2.41B
avg. 5.15%
Avg: $2.45B
Low: $2.43B
High: $2.47B
avg. 2.35%
EPS
 
% change YoY
$15.9
 
N/A
$8.12
 
-48.93%
$7.59
 
-6.52%
Avg: $8.51
Low: $8.18
High: $9.5
avg. 12.14%
Avg: $9.4
Low: $8.96
High: $10.66
avg. 10.44%
Avg: $11.09
Low: $10.97
High: $11.22
avg. 18.00%
Avg: $11.87
Low: $11.73
High: $12
avg. 7.00%
Operating Expenses
 
% change YoY
$1.82B
 
N/A
$2.00B
 
9.68%
$1.61B
 
-19.70%
Avg: $1.71B
Low: $1.70B
High: $1.73B
avg. 6.31%
Avg: $1.77B
Low: $1.75B
High: $1.78B
avg. 3.45%
Avg: $1.86B
Low: $1.84B
High: $1.87B
avg. 5.15%
Avg: $1.90B
Low: $1.88B
High: $1.92B
avg. 2.35%

FAQ

What is Quest Diagnostics Incorporated stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 12.01% in 2025-2028.

We have gathered data from 12 analysts. Their low estimate is 924.34M, average is 970.18M and high is 1.07B.

What is Quest Diagnostics Incorporated stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 4.12% in 2025-2028.

We have gathered data from 13 analysts. Their low revenue estimate is $9.71B, average is $9.76B and high is $9.90B.

What is Quest Diagnostics Incorporated stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 11.89% in 2025-2028.

We have gathered data from 12 analysts. Their low earnings per share estimate is $8.18, average is $8.51 and high is $9.5.

What is the best performing analyst?

In the last twelve months 6 analysts have been covering Quest Diagnostics Incorporated stock. The most successful analyst is Patrick Donnelly.